Stem cell stocks are under pressure after yesterday's ruling by a federal judge that blocks...
Stem cell stocks are under pressure after yesterday's ruling by a federal judge that blocks federal funding for research involving human embryonic stem cells. STEM -6.3%, GERN -3.8%, CYTX -3.6%, ASTM -3.3%, ATHX -2.8%, SGMO -1.4%, OSIR -0.6%.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs